We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2007 by Sheba Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00426062
First Posted: January 24, 2007
Last Update Posted: February 21, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
Study comparing level of free radicals in tumor tissue, blood serum and saliva in patients with Squamous Cell Carcinoma of tongue and mouth floor. Patients with benign fibroma of oral cavity and normal gingiva around extracted lower wisdom tooth are used for control

Condition Phase
Squamous Cell Carcinoma Phase 1

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Older than 18 years of age.
  2. Mentally healthy
  3. SCC of Tongue or Mouth Floor
  4. Benign Fibroma of Oral Cavity
  5. Lower wisdom tooth extraction -

Exclusion Criteria:

  1. Younger than 18 years of age
  2. Mentally incapacitated
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00426062


Contacts
Contact: Alex Dobriyan, DMD 972-3-6040306 lancet72@gmail.com
Contact: Ran Yahalom, DMD 972-3-5303819 ranyahalom@gmail.com

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Alex Dobriyan, DMD Sheba Medical Center
Principal Investigator: Ran Yahalom, DMD Sheba Medical Center
Principal Investigator: Rafi Nagler, DMD,MD Rambam Health Care Campus
  More Information

ClinicalTrials.gov Identifier: NCT00426062     History of Changes
Other Study ID Numbers: SHEBA-06-4116-AD-CTIL
First Submitted: January 23, 2007
First Posted: January 24, 2007
Last Update Posted: February 21, 2007
Last Verified: February 2007

Keywords provided by Sheba Medical Center:
Squamous Cell Carcinoma of Tongue and mouth floor

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell